NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $238 | -31.4% | 19,350 | -10.3% | 0.00% | 0.0% |
| Q2 2023 | $347 | +20.1% | 21,562 | +29.9% | 0.00% | 0.0% |
| Q1 2023 | $289 | -99.9% | 16,605 | +29.3% | 0.00% | -50.0% |
| Q4 2021 | $438,000 | -66.5% | 12,844 | -52.7% | 0.00% | -60.0% |
| Q3 2021 | $1,309,000 | +65.9% | 27,128 | +55.4% | 0.01% | +25.0% |
| Q2 2021 | $789,000 | -19.2% | 17,460 | -13.7% | 0.00% | -20.0% |
| Q1 2021 | $976,000 | +60.3% | 20,240 | +78.8% | 0.01% | +25.0% |
| Q4 2020 | $609,000 | – | 11,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |